INTERNATIONAL BIOTECHNOLOGY TRUST PLC - ORIC PHARMACEUTICALS INC ownership

ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 102 filers reported holding ORIC PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of ORIC PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$905,000
-59.8%
176,217
+15.2%
0.20%
-59.3%
Q4 2021$2,249,000
+103.7%
153,000
+188.7%
0.50%
+88.3%
Q3 2021$1,104,000
+17.7%
53,0000.0%0.27%
+7.3%
Q2 2021$938,000
-27.7%
53,0000.0%0.25%
-27.7%
Q1 2021$1,298,000
-27.4%
53,0000.0%0.34%
-29.9%
Q4 2020$1,789,00053,0000.49%
Other shareholders
ORIC PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 602,272$2,698,0008.92%
Column Group LLC 3,568,181$15,985,0003.40%
Euclidean Capital LLC 747,550$3,349,0002.85%
Invus Financial Advisors, LLC 1,007,575$4,514,0002.72%
SILVERARC CAPITAL MANAGEMENT, LLC 1,082,304$4,849,0001.49%
Monaco Asset Management SAM 364,741$1,634,0000.71%
EcoR1 Capital, LLC 3,418,068$15,313,0000.53%
DAFNA Capital Management LLC 415,926$1,863,0000.51%
Boxer Capital, LLC 1,054,000$4,722,0000.30%
Casdin Capital, LLC 601,515$2,695,0000.23%
View complete list of ORIC PHARMACEUTICALS INC shareholders